Prostate Neoplasms Completed Phase 1 / 2 Trials for Abiraterone (DB05812)

Also known as: Neoplasm, Prostate / Neoplasms, Prostate / Prostate Neoplasm

IndicationStatusPhase
DBCOND0031071 (Prostate Neoplasms)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00473746Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate CancerTreatment